Mrs. Cassie Davidson Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5330 Laytham Pike, Mays Lick, KY 41055 Phone: 606-763-6255 Fax: 800-584-1465 |
News Archive
AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.
In today's headlines, Romney wins a historically close contest in Iowa caucuses and Wall Street Journal readers favor televising the Supreme Court arguments regarding the health law.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.
An analysis demonstrating the ability of DX-88 (ecallantide) to resolve symptoms of acute hereditary angioedema (HAE) attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology (ACAAI) 2009 Annual Meeting in Miami Beach.
› Verified 8 days ago